Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Aug;29(8):703-12.
doi: 10.1007/s10815-012-9784-0. Epub 2012 May 15.

Leiomyoma: genetics, assisted reproduction, pregnancy and therapeutic advances

Gary Levy  1 , Micah J Hill, Stephanie Beall, Shvetha M Zarek, James H Segars, William H Catherino
Affiliations
Review

Leiomyoma: genetics, assisted reproduction, pregnancy and therapeutic advances

Gary Levy et al. J Assist Reprod Genet. 2012 Aug.

Abstract

Purpose: Uterine leiomyomas are common, benign, reproductive tract tumors affecting a majority of reproductive aged women. They are associated with gynecologic morbidity and detrimentally affect reproductive potential. The etiology of leiomyomas is poorly understood and their diagnosis prior to treatment with Assisted Reproductive Technologies (ART) represents a management dilemma. The purpose of this paper is to review known genetic and molecular contributions to the etiologies of leiomyomas, describe their impact on ART outcomes and reproductive potential, and review alternative therapies and future directions in management.

Methods: A critical review of the literature pertaining to genetic component of uterine leiomyomas, their impact on ART and pregnancy and leiomyoma therapeutics was performed.

Results: Uterine leiomyomas are characterized by complex molecular mechanisms. Their location and size determines their potential detriment to ART and reproductive function and novel therapeutic modalities are being developed.

Conclusion: The high prevalence of uterine leiomyomas and their potential detrimental influence on ART and reproductive function warrants continued well-designed studies to ascertain their etiology, optimal treatment and novel less morbid therapies.

PubMed Disclaimer

References

    1. Bowden W, Skorupski J, Kovanci E, Rajkovic A. Detection of novel copy number variants in uterine leiomyomas using high-resolution SNP arrays. Mol Hum Reprod. 2009;15:563–8. doi: 10.1093/molehr/gap050. - DOI - PMC - PubMed
    1. Laughlin SK, Schroeder JC, Baird DD. New directions in the epidemiology of uterine fibroids. Semin Reprod Med. 2010;28:204–17. doi: 10.1055/s-0030-1251477. - DOI - PMC - PubMed
    1. Marino JL, Eskenazi B, Warner M, Samuels S, Vercellini P, Gavoni N, et al. Uterine leiomyoma and menstrual cycle characteristics in a population-based cohort study. Hum Reprod. 2004;19:2350–5. doi: 10.1093/humrep/deh407. - DOI - PubMed
    1. Okolo S. Incidence, aetiology and epidemiology of uterine fibroids. Best Pract Res Clin Obstet Gynaecol. 2008;22:571–88. doi: 10.1016/j.bpobgyn.2008.04.002. - DOI - PubMed
    1. Payson M, Leppert P, Segars J. Epidemiology of myomas. Obstet Gynecol Clin North Am. 2006;33:1–11. doi: 10.1016/j.ogc.2005.12.004. - DOI - PMC - PubMed